❭ Research by medical division ❭ Laboratory Medicine ❭ Medical Genetics ❭ Cancer Genome Variation [Kristensen] ❭ Research projects ❭

Reseach project overview, Vessela N. Kristensen's group: Cancer Genome Variation

  • Genomic instability and treatment response
  • Integrated pathway analysis in breast cancer
  • The epigenetic landscape of cancer: application for prognostic and predictive biomarkers
  • Functional cellular, explant- and organoid systems
  • Integrated molecular analysis of miRNAs in breast cancer with clinical outcome
  • Genetic and epigenetic mechanisms underlying treatment response
  • Germline biomarkers for clinical management of sporadic and familiar tumors
  • The immune system in breast carcinogenesis and treatment response
  • NorMa: Normal mammary tissue and cancer development
  • Sequencing the non-canonical genomes
 
Page visits: 11755
Scroll to top

Home Medical Genetics Cancer Genome Variation [Kristensen]

  • Group members
  • Group member list, by study
  • Research projects
  • Publications
  • News
  • Vacant positions
  • Funding and grants
  • Nina Iversen's project group
  • Xavier Tekpli's project group

Recent publications

Daniel P, Balušíková K, Václavíková R, Šeborová K, Ransdorfová Š, Valeriánová M, Wei L, Jelínek M, Tlapáková T, Fleischer T, Kristensen VN, Souček P, Ojima I, Kovář J (2023)
ABCB1 Amplicon Contains Cyclic AMP Response Element-Driven TRIP6 Gene in Taxane-Resistant MCF-7 Breast Cancer Sublines
Genes (Basel), 14 (2)
DOI 10.3390/genes14020296, PubMed 36833223

Morra A, Mavaddat N, Muranen TA, Ahearn TU, Allen J, Andrulis IL, Auvinen P, Becher H, Behrens S, Blomqvist C, Bojesen SE, Bolla MK, Brauch H, Camp NJ, Carvalho S, Castelao JE, Cessna MH, Chang-Claude J, Chenevix-Trench G, NBCS Collaborators, Czene K, Decker B, Dennis J, Dörk T, Dorling L et al. (2023)
The impact of coding germline variants on contralateral breast cancer risk and survival
Am J Hum Genet, 110 (3), 475-486
DOI 10.1016/j.ajhg.2023.02.003, PubMed 36827971

Morra A, Schreurs MAC, Andrulis IL, Anton-Culver H, Augustinsson A, Beckmann MW, Behrens S, Bojesen SE, Bolla MK, Brauch H, Broeks A, Buys SS, Camp NJ, Castelao JE, Cessna MH, Chang-Claude J, Chung WK, Collaborators N, Colonna SV, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Dennis J et al. (2023)
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
Res Sq
DOI 10.21203/rs.3.rs-2569372/v1, PubMed 36824750

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Email: trond.olav.berg@rr-research.no

Cookie policy

Accessibility statement (in Norwegian)